Status:
TERMINATED
Determination of the Aneurysm Vulnerability Index by Stimulation and Medical Imaging
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Aneurysm
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Stroke is the leading cause of disability in France with 130,000 cases per year, 20% of strokes being hemorrhagic, with a majority of intracranial aneurysm rupture (80%). Each year, 6000 meningeal hem...
Eligibility Criteria
Inclusion
- Age limits to \> 18 years
- Collection of the informed consent (patient or legal representant)
- Affiliation or recipient with the mode of social security
- \- Groupe anévrysme rompu
- Patient porteur d'un anévrysme rompu
- \- Groupe anévrysme non rompu
- Patient porteur d'un anévrysme non rompu
Exclusion
- Subject presenting contraindications in MRI (Ferromagnetic foreign bodies, pace-maker …)
- Claustrophobia
- Women pregnant or Breast-feeding
- Patient participating in an other study
- Patient have participated in a study in the 3 months before the inclusion
- In period of exclusion relative to another protocol
- Person with majority age protected by the law (supervision or trusteeship).
- Patient not reading the french language
- Patient or representant for whom it impossible to give accurate informations
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05189041
Start Date
June 1 2014
End Date
December 1 2017
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
COSTALAT
Montpellier, France, 34295